Skip to main content
Premium Trial:

Request an Annual Quote

Big Data Analysis Firm Ayasdi Raises $30.6M in Series B Financing

NEW YORK (GenomeWeb News) – Big data analysis firm Ayasdi said this week it raised $30.6 million in a Series B funding round.

Institutional Venture Partners led the round. Additional participants included Citi Ventures, GE Ventures, and existing investors Khosla Ventures and Floodgate.

In conjunction with the investment, IVP's Steve Harrick is joining Ayasdi's board.

The funding will go toward acceleration of the Palo Alto, Calif.-based company's development of machine learning systems and topological data analysis –based approaches.

Founded in 2008, Ayasdi is a spinout of Stanford University and has developed a platform called Ayasi Iris "to automatically find insights from complex data and operationalize them." The method combines advanced machine learning techniques with toplological data analysis, which is a branch of mathematics, to discover insights without coding scripting, or manual querying.

The first version of the platform was launched in 2011 and Ayasdi initially sold it to clients in the pharmaceutical space and government organizations, such as the US Food and Drug Administration, a company official told BioInform earlier this year.

Other clients include the, Merck, the Mt. Sinai Medical Center, and the University of California, San Francisco.

Ayasdi raised about $10.3 million in a Series A financing round in January.

Filed under

The Scan

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.

Study Points to Synonymous Mutation Effects on E. Coli Enzyme Activity

Researchers in Nature Chemistry saw signs of enzyme activity shifts in the presence of synonymous mutations in a multiscale modeling analysis of three Escherichia coli genes.

Team Outlines Paternal Sample-Free Single-Gene Approach for Non-Invasive Prenatal Screening

With data for nearly 9,200 pregnant individuals, researchers in Genetics in Medicine demonstrate the feasibility of their carrier screening and reflex single-gene non-invasive prenatal screening approach.

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.